Absorbable scaffold beats angioplasty for lower-leg artery disease

In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Triangle Fire history preserved by ILR’s Kheel Center

Steps from where dozens of young immigrant Jewish and Italian women died when a fire erupted in the locked sweatshop, 60 Cornell students, faculty, staff and alumni gathered Oct. 11 to honor the legacy of the Triangle Shirtwaist Factory tragedy.

Around Cornell

Drug screen points toward novel diabetes treatments

A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.

Boosting beta cells to treat Type 2 diabetes

Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.

New culprit in amyloid beta buildup, neurodegeneration

Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain. This triggers a reaction that damages blood vessels and causes neurodegeneration.

U.S. Secretary of transportation encourages students to participate in local politics

U.S. Secretary of Transportation Pete Buttigieg provided an intimate look at the most pressing issues in federal infrastructure planning during a conversation on November 2 with students and faculty members from the Cornell Jeb E. Brooks School of Public Policy and the Roosevelt House Public Policy Institute at Hunter College.

Around Cornell

Mobile units increase odds of averting stroke

Receiving a clot-busting drug in an ambulance-based mobile stroke unit increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, a new study shows.

Gut fungi amplify inflammation in severe COVID-19

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

Estrogen therapy’s effect on Alzheimer’s needs more study

Research findings suggest that women who took hormones in midlife to treat their menopause symptoms were less likely to develop dementia than those who hadn’t taken estrogen.